Why “reprogramming” is the buzziest approach to reversing aging right now
MIT Tech ReviewPaywall
Read Full Article at MIT Tech Review →
Ad Slot — In-Article (728x90)
Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball.
The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye.
This is a summary. For the full story, read the original article at MIT Tech Review.
Original source: MIT Tech Review